Time to read: 10 minutes
Updated Thu, Nov 18, 2010 @ 08:08 AM
Originally Published Thu, Nov 18, 2010 @ 08:08 AM
Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has licensed access to the new “pdm” H1N1 signatures from Centers for Disease Control and Prevention (CDC). The new “pdm” panel is optimized to achieve enhanced sensitivity and specificity for H1N1 specimen.
To read the entire story, read the full press release.